New Algorithm Predicts Prostate Cancer Recurrence for Radiation Therapy Patients
Researchers developed a patent-pending method and algorithm to predict prostate cancer recurrence in patients treated by radiation therapy.
Read MorePosted by Andy Lundin | Oct 9, 2023 | Prostate |
Researchers developed a patent-pending method and algorithm to predict prostate cancer recurrence in patients treated by radiation therapy.
Read MorePosted by Andy Lundin | Oct 4, 2023 | Cancer, Company News |
EValuate Diagnostics aims to make tests that detect cancer early, and will market a system for the capture of extracellular vesicles.
Read MorePosted by Andy Lundin | Oct 2, 2023 | Prostate |
Black patients seen by a precision medicine navigator were substantially more likely to receive genomic testing than those who were not.
Read MorePosted by Andy Lundin | Sep 29, 2023 | Cancer |
Point32Health and GRAIL announced the expansion of their pilot to offer GRAIL’s Galleri multi-cancer early detection screening test.
Read MorePosted by Chris Wolski | Sep 4, 2023 | POC Rapid Assays |
Hilab showcased its point-of-care Hemogram device capable of delivering a complete blood count with the assistance of artificial intelligence.
Read More